Hepatic allograft transplantation has become an accepted form of therapy for treatment of a variety of Ijfe-threatening liver diseases [1] [2] [3] [4] . The indicacions for this procedure range from end-stage liver failure, due to a variety of causes, to patients with inborn errors in metabolism and hepatic malignancy. The success of this procedure has been well documented. With the advent of cydosporine immunosuppression. 60-70% ~-yr survival rates are being achieved [1] . Re;ec-. . tion continues to be a major cause of graft dysfunction. in spite of tech'lological and immunosuppressive advances (1, 4] .
While little is known about the immunobiology of hepatic rejection, several observations point out possible differences from other allograft rejection models. The ability to transplant cadaveric liven in spite of a positive lymphocytotoxicity cross-match and across ABO incompatibilities highlight possible differences in allorecognition [5, 6] . Whether this reflects the unique anatomic architecture of the liver, or whether there are differences in the expression of alloantigens. is not known. Several studies have demonsuated disparity of expression of class I and class II MHC antigens on normal liver vasculature when compared to other vascularized organs [7.B] .
While most current models of aIlorecognition and subsequent rejection assign T lymphocytes a central role [9] . little is known regarding the function of these cells or their contribution to the severity of graft rejection. Immunohistochemical staining of organ transplant tissues with monospecific cell surface marker antibodies has given conflicting data on the CD4 and CDB marken l of infiltrating T cells [11] [12] [13] [14] . These studies have other limitations: (i) inability to correlate cell surface markers with functional characteristics of the ce[s in question. and (ii) presence of "irrelevant" mononuclear cell infiltrates in the absence of clinical rejection within the allograft (15.16). Several models have therefore been advanced to study the functional characteristics of infiltrating graft cells and their role in rejection. In vitro functional assays of enzymarically isolated lymphocytes from rejected organs have demonstrated allospecificity (17] . The sponge-allograft model has been employed to study the kinetics of graft infiltration (lB.19J. Recent advances in T-cell culture technology have enabled the propagation and expansion of activated T cells from allograft biopsies. Kim et aI. have shown that cloned noncytotoxic T -cell lines from mouse skin allografts could mediate rejection when reinjected into naive animals (20) . Both Moreau et aI. (21) . and Mayer et al. [22] . have described isolation of functionally active allospecific human T -cells lines propagated from either percutaneous biopsies or rejected renal grafts. We have recently described the allospecificity of T cells grown from serial endamyoc!Udiai biopsies from heart allograft recipients. and demonsttated both class I and class II HLA recognition (23).
We are interested in undentanding the mechanisms of allorecognition and hc:patic rejection. Because immunologic monitoring of peripheral blood has 1;-itUions in these patients (24), we have routinely obtained liver core biopsies during an episode of hepatic allograft dysfunction for histologic confirmaticn of cellular infiltration. Utilizing T-cell culture techniques. we report the functional character~zation of expanded T cells from these biopsies.
MATERIALS AND METHODS
SDllrn """mal. Samples of hepatic allografts were obtained from clinical material taken from percutaneous liver biopsies. intraoperative liver biopsies. or allograft hepatectomies. The patient profile is shown in Table 1 . All transplant recipients were placed on post-operative intravenous cyc1osporine A and steroids, as maintenance immunosuppression. Indicanons for sampling were derangements in liver function tests and bile composition via T-tube drainage from the allograft [2H bulk cultured biopsy T cells to irradiated donor lymphocytes, by monoclonal anci-class I and anti-class II antibodies, was accomplished according to previously described methods [32] . Briefly, the same number of scimulator and responder cells as for PLT, in 100 pJ TCM, were coincubated with 100 pJ of various MoAbs.
The following MoAbs, with their corresponding HLA molecular specificity, were used: SG 15 7 (anti-DR) and SG465 (broad anti-class II) (5. Goyen and J. Silver
[33]); L243 (anti-DR) and Leu 10 (anci-DQwl + w3) (Becton Dickinson, Mountain View, CA (34) (35) (36) ); and PA2.6 (anti-HLA-A,B,C) (P. Parham (37, 38] ). The PLT activity was measured in a 72-hr assay as described above.
Ctll meJialtJ cyloloxicity (CML).
The CML activity of lymphocyte cultures grown from liver samples was measured in 4-hr 'ICr release assays, according to previous descriptions for alloreactive T-cell clones (31] with slight modifications as noted. Briefly, targets were 4-day PHA stimulated spleen cells (class I targets) or EBVtransformed spleen cells (class I and II targets) from the donor or other HLAtyped panel cells (LCL). An effecror:wget ratio of 10: 1 was used to measure release of labeled chromium from 2 x 10 3 labeled target cells. A measured aliquot of supernatant was mixed with a high-d'6ciency aqueous compatible scintillation counting mixture (READY-SOLV HPIb, Beckman Instruments, Fullerton, CA) and coueued in a liquid scintillarion counter. The percentage of CML expressed was calculared from a formula which represents a ratio of experimental to total <determined by lriton-X release) "Cr release (subtracting spontaneous release) [32] .
CtU sur/au phmoIJPi( "",,/ysis. Lymphocytes grown from liver samples were tested for various T -<ell differentiation antigens using a modification of the avidin-biotinimmunoperoxidase technique (39] . The following differentiation markers were J. J. Fung et aI.
. analyzed: CD3 (pan-T cell), CD4 ("helper/inducer T cell"), and COS ("cytotoxidsuppressor T cell") (OKT series purchased from Orrho Diagnostics, Rantan, N); Leu series purchased from Becton Dickinson. Sunnyvale. CAl. In addition. anti-DR staining was similarly done using a monoclonal anti-HLA-DR (Becton Dickinson). Briefly, cytocentrifuge smears were prepared. using 2.5 X 1 ()4 ceIWslide, and fixed in acetone immediately after preparation. A total of 200-400 cells were enumerated.
HLA phmotyping. Peripheral blood lymphocytes, donor spleen cells, and Iymphoblastoid cell lines (LCL) were typed for HLA A, and B antigens by the standard NIH microlymphocytotoxicity technique. Serologic typing for HLA DR was done by prolonged incubation microlymphocytotoxicity test using enriched B-cell preparations obtained following carbonyl-iron treatment and Ficoll-H ypaque sedimentation after rosetting with neuraminidase treated sheep red cells.
Statistical analysis. Cultured lymphocytes were defined as reactive towards a given stimulator cell in proliferation assays when the tOtal incorporated sH_ thymidine COunt ± 2 SO was greater than background counts (i.e., counts with cultured lymphocytes with 10% AB serum alone plus irradiated stimulator cells with 10% AB serum alone) ± 2 SO. Analysis of statistical significance was done using the Chi square test.
RESULTS
Patient/Sample Profile Lymphocytes were grown from 18 biopsies obtained from 14 liver transplant patients. Table 1 summarizes the salient features of these patients including age, sex, primary diagnosis at the time of transplantation, the post-transplant day of the biopsy, and the current status of the allograft. In this paper, each liver biopsy (LB) culture is referred to by a unique number which identifies the patient and the post-transplant day when the biopsy was obtained. In addition, the letters A and B designate the first and second allografts, respectively. For example, LB 1. 7 B was obtained from patient 1 on day 7 post-transplant from the second allograft ~d LB2.16A was obtained from patient 2 on day 16 post-transplant from the first liver transplant. This representative population of transplant patients included patients with end-stage liver failure due to a variety of causes as well as patients with inborn errors of metabolism and hepatic malignancy (Table 1) . Biopsies were obtained from 11 first transplants and five second transplants, including ~o patients (9 and 13), who provided specimens from both first and second allografts. The interval from transplantation to biopsy ranged from 3 days to 330 days, with a median of 14 days post-transplant.
Generation and Expansion of Amvated T Lymphocytes from Liver Biopsies Biopsies obtained from hepatic allografts were incubated in viero, in the presence of recombinant human 11.,2, but without the addition of irradiated feeder cells.
After 2-3 days, an outgrowth of mononuclear cells was seen (FIgUre 1). The cultureS were supplemented at 2-3 day intervals with 11.,2 and transferred into larger wells. Expansion was continued until confluence was obtained. generally within 10-14 days following initial biopsy. Sufficient number of cells (5 x 10 1 -1 X 10') were then obtained for functional assays and phenotypic analysis. Phenotype analysis of biopsy-grown mononu<:lear cells showed a predominance of CD3 positive T lymphocytes. many of which also expressed DR antigens (an indication of activation [40] ). Biopsy cultured lymphocytes were typed phenotypically berween 2 and 4 weeks following sampling. Table 2 lists representative results which also demonstrate a mixture of CD4 and CDS positive cells in most cultures. Among seven lymphocyte cultures tested, there seemed to be an overall trend towards CD4 predominance. although statistical significance could not be established, possibly because of small sample size. In rwo patients (S and 10), who had undergone a percutaneous liver biopsy, subsequent allograft hepatectomy was required for unremitting rejection shortly thereafter. Cells from these rejected livers, extracted by mechanical disruption followed by Ficoll-Hypaque purification and then directly analyzed, showed very similar phenotype profiles co cells grown from the biopsies ( Table 2) .
Allospecificity of Infiltrating Allograft T Cells in Secondary Proliferation
The alloreacavity of biopsy-grown lymphocytes was determined in secondary proliferation assays (PLT). Table 3 shows the proliferative responses of biopsycultured lymphocytes to irradiated spleen cells from the transplant donor and also to exogenous IL-2 in 3-day assays. All cultured lymphocytes exhibited low spontaneous thymidine incorporation and high proliferative responses to IL-2 suggesting the presence of activated T cells with receptors for 11-2 ( Table 3 ). The majority of expanded lymphocytes also showed strong proliferative responses to original donor lymphocytes. However, five biopsy-grown lymphocyte cultures expressed little or no PLT reactivity towards donor cells (LB2.16A, LB4.12A, LBl1.3A, LB12.3A, and LB14.30A>. When the phenotypes of these cultured T cells were correlated with donorspecific proliferation, no correlation berween a predominance of CDS bearing cells ("suppressor/cytotoxic" subset) and a lack of proliferation could be found.
We next compared the cause of graft dysfunction with the ability of the cultured lymphocytes to proliferate against donor cells. A statistically significant correla-. . . . Biopsy-growa lymphocyteS were also teSted for PLT specificity qaiast a panel of uarelaced cells selected co sbare liLA antigens with the oripaal ttaasplant donor. 10 mao, iascaaca. it was possible to determioe the allospecificicy of these aDs. Table" I1IIIUIWiza the appueat PLT specificity for those cultured lymphocyte lines that proliferaled spiDle donor HLA specificities. Three biopsies hid PLT specilicities limited to class I antigens, seven were class II specific. wbereu three biopsies appeared to concaia cells that recopize both class J and II donor an ..... Ilepraeawive examples of resula of the PLT aaaI,sis on biopsy-growa lymphocytes from three par.ieoa are described below.
P.,iftI; 3. Pacieae 3. who was HLA typed A2",26; B3S,w41; DIU.S; received. lMruansplaatfromadooorwbo typed asA~l,28; B3S,w60; Dllw6,7. On posttnasplaat day 32, the paieat developed elevaced liver enzymes while uluasound sNdies indicated aormal aUosnft architecture. The hiltolosy of. percutaneOUS liver biopsy showed subintimal lymphocytic infiltrates in the portal triads consistent with mild rejection. .. The PLT specificity of LB3.32A was associated with DRw6 and DR7 antigens; all six positive stimuJaror ceDs bore either anti&en specificity whereas all of the (our neprive ceDs lacked these class II antigens (Fagure 2). (Table S) . In spite of aggressive immunosuppression the patient had continued clinical deterioration requiring allograft hepateaomy followed by retransplantation 4 days later. Fragments of the first donor liver (LBS.13A) were incubated under conditions similar to the initial biopsy and the expanded cells were tested .pnst the same panel of cells. Histolosically, the portal infiltrate appeared less extensive but a residium of lymphocyteS and macrophages was noted, consistent with resolving rejeaion. As shown in Table 5 . specificities to which these cells reacted towards were B1S and DRS. AU four B1S positive stimulator cells and all seven DR5 positive panel cells stimulated T cells expanded from this biopsy, whereas five of five B IS and DR5 Deprive panel cells failed to do so. Thus it appears that within the interim. acquisition of DR5 reactivity appeared.
H-THYMIOINE UPTAKE (<PM)
Pa,i,,,, 9. Patient 9. typed as Al,-; B3S,w62; DR5,w6; received a first allograft from an A26.11; B1S.w41; DR2,5 donor. Following initial satisfactory function. elevation of the serum bilirubin 5 days post-transplant necessitated a percutaneous liver biopsy for diagnosis. Histologically. there was no portal infiltrate and no -Jymphocytes could be grown from the biopsy. Four days later, however. because of increasing liver dysfunction, an allograft hepateaomy was performed. At this time. histologically there was moderate portal tract infiltrates with biliary epi- other donor-specific antigens (Figure 3) . The second donor was typed as A2,24; B7,49: DR2,4. Again, after initial function, deterioration of liver function occurred. A percutaneous liver biopsy (LB9.11 B) was done 11 days after the second transplant revealed severe cholestasis with moderate portal lymphocyte infiltration and evidence of bile duct injury. T cells were expanded from this biopsy and as shown in Table 6 ; allospecificity was determined to be against DR4 and possibly B7. Nine of the nine stimulator cells bearing these antigens induced proliferation of the biopsy cultured T cells in PLT. None of the five DR4 or 87 negative cells induced proliferation in this cell line. We found only slight PLT reactivity ofLB9.11B cells towards cells from the first transplant donor (donor A).
Finally. after 39 days following the second transplant, in spite of~igorous efforts to reverse rejection. another allograft hepatectomy with retransplantation was required for iotractible rejection. as verified by histology. Cells grown from this sample (LB9.39B) were tested in PLT and revealed a similar pattern to cells obtained 4 weeks earlier. although a broader reactivinr pattern was noted from the latter liver sample (Table 6 ).
Monoclonal Antibody Inhibition Profiles in PL T
A panel of defined monoclonal anti-HLA antibodies were used to inhibit proliferation of cultured biopsy lymphocytes towards irradiated donor stimulator cells. As shown in Table 7 , the alIoreactivity of the biopsy-cultured cells, as determined by immunogenetic: analysis, was verified by blocking experiments w~th these MoAbs. Additiooof the class I specific MoAb. P A2.6, to cells grown from LB 1. 78 fIGURE 3 PLT specificity of LB9.9A. Legend is the same as for Fisure 2. The background count was 222 :t 23 (1 SO). 'F"anr doacw.
3H-THVMlDINE UPTAKE <CPM)
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(with PLT specificity towards class I donor antigens) resulted in. 51.7% reduction of.dooor-stimulated proliferation. In conuut. none of the class II specific MoAbs sigoificandy inhibited LBl.7B proliferation.
The fine degree of disc:rimioarion of these MoAbs was also evident in the : inhibition profiles of LB7.5A and LB13.28B, both of which demonstrated class IlrelCtivity by PLT analysis. Cultured ceUs from both biopsies were not inhibited by P A2.6, while sipificant inhibition of prolifenrion was observed with the class II specific MoAhs. 
Donor-Specific T-Cell Mediated Cytotoxicity
In several instances, CML assays were used to assess the ability of..expanded biopsy-cultured T cells to lyse donor targets. Using PHA transformed T lymphoblasts and/or E8V-transformed 8 Iymphoblastoid cell lines (derived from original donor spleen cells) as targets, cytotoxcity was determined at a 10: 1 effector/target ratio. As shown in Table 4 , several T-cell lines demonstrated significant cytOtoxicity towards donor specificities. In general, those lines showing significant cytotoxicity in this assay correlated to class I antigen induced proliferation in PLT assays. In patient M.S., LB 13.288, in vitro expanded intragraft T cells demonstrated DR3 allospecificiry in PLT assay. The recipient was HLA typed as Al,24; B35,w55; 0R2.5 while the donor typed as Al.2; B51.8; OR3,7. CML assay showed 21% cytolysis of mY-transformed donor cells which correlated with CML specificity against the DR3 antigen. There was a much lower level of lympholysis against the PHA-transformed donor lymphoblast line (8%) and a significant lympholysis (32%) against another OR3 positive lymphoblastoid cell line (Figure 4 ). Therefore, while the general rule that class I antigens serve as targets for cell mediated lympholysis, class II antigens can also serve as recognition structures for cellmediated lympholysis [41, 42] .
DISCUSSION
We describe methodologies based upon our previous' experiences allowing expansion and characterization of intragraft T-cell populations in hepatic allografts [23] . The rationale behind our approach is based on acquisition of lL-2 receptors Kumick and co-workers. usina. similar approach, have reccndy reponed their results chanctaizina apaoded TeeDs from rejectina renal aUosraft from patients on azathioprine and prednisone immunosuppression (22] . Phenotypic analysis of their ceU lines showed • predominance of cells bearing the CDS phenotype, although they also noced that in one patient treated with cyciosporine, that the CD4 and CDS populations were almost equal. The differences in the immunosuppression regimens may indeed explain the more frequent expression of CD4 populations in our series, and has been noted in other human allograft models [26, 48, 49] .
We have shown, by immUQOSeDCtic analysis. that both class I and class II HLA determinants can sene as recopition anrisens-In several instances, diese PLT findings were vcri6cd by monoclonal anti-HLA antibody inhibicioo profiles. In our preYious studies with aIIoreaaive T -cen clones (32] 
